WallStreetCorner Posts Research Report on Advanced Plant Pharmaceuticals
BLUFFTON, S.C. , Jan. 20, 2004 (PRIMEZONE) -- WallStreetCorner has posted a research report on Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI). The report is accessed in the Special Situation section on the home page of www.WallStreetCorner.com.
Cites Momentum in Developing Distributor Network for Significant Capital Appreciation Potential
The report cites the recent success in developing a domestic and international direct distribution network for APPI's flagship product, Lo-Chol (tm), a cholesterol-lowering supplement. In addition, an Internet distributor has recently gone "live" with its new website at www.lo-chol.com. Noting that the infomercial campaign with Mr. Ed McMahon as the spokesperson will begin airing in the near future, sales momentum is expected to accelerate globally. With only five foreign country distributors announced to date, additional distributor announcements are expected by the editor. In addition, APPI's second product, Sinusol(tm) (a homeopathic nasal spray) is expected to contribute to revenues going forward.
The analysis of APPI includes a market capitalization comparison that prompted the editor to note, "If APPI reached a market capitalization of $89 million, assuming the same number of shares outstanding, APPI stock would be valued at approximately $0.18 per share. (See Market Cap Comparison below). As the planned aggressive marketing campaign of Lo-Chol(tm) converts to projected rapidly increasing sales, along with an aggressive rollout of Sinusol(tm) during this winter's flu season, this target valuation could prove conservative as investors begin to become aware of the new APPI."
The editor concluded: "One important consideration is the fact that APPI is a lean operation. The profit margins are healthy, & management sub-contracts all production & marketing, so its overhead structure is low, & should remain low as sales increase. APPI is an emerging situation -- small now, but with the distinct possibility of rather attractive appreciation potential."
About WallStreetCorner: Formed five years ago as a venue for the Conservative Speculator newsletter, published since 1987, WallStreetCorner, including Conservative Speculator and Larry Oakley's "Stock Pick," "Opinion," and "Comment" editorial columns, is now regularly read by investors in 72 countries. WallStreetCorner has accepted a cash payment of $1,500 for preparing and posting the APPI research report.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: |
